skip to content
  1. Home
  2. >
  3. Questions
  4. >
  5. NTR: Hi, Last week it reported Q1-2025 earnings. [Nutrien Ltd.]
You can view 2 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: Hi,
Last week it reported Q1-2025 earnings. It missed its EPS and revenue also come lower but from the share price movement this news is considered as positive as share price reached 12 month high. Can you please give your analysis on this kind of scenario? Is this considered as selling opportunity to take advantage of rally or there is some positive news under the numbers which normal investor did not see?
Piyush
Asked by Piyush on May 22, 2025
5i Research Answer:

EPS of $0.153 missed estimates of $0.497 and revenues of $6.77B missed estimates of $7.4B. Management maintained its 2025 full-year guidance ranges, and in Q1 it delivered strong potash sales volumes, and positioned its downstream retail network for a strong expected spring planting season in North America. Management noted the global fertilizer market fundamentals have strengthened supported by growing demand and limited supply.

While the company saw a decline in sales and earnings, the market is likely encouraged by management's commentary on a positive potash market going forward. From a technical standpoint, NTR has seen a shift in momentum, where its price trend was making new lows until late 2024, when it began to make higher lows and highs. We feel this is a reflection of its large position in the global fertilizer industry, and a potential reversal in potash prices. We would be comfortable holding here.